Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,626.00
Bid: 1,626.00
Ask: 1,626.50
Change: -140.50 (-7.95%)
Spread: 0.50 (0.031%)
Open: 1,616.50
High: 1,637.50
Low: 1,589.50
Prev. Close: 1,766.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks fall ahead of UK inflation data

Tue, 12th Nov 2013 08:22

- Markets eye inflation data- BoE Inflation Report due tomorrow- Corporate earnings come in mixedtechMARK 2,636.87 -0.14%FTSE 100 6,706.83 -0.32%FTSE 250 15,395.24 -0.16%UK markets opened lower on Tuesday morning as investors refrained from building positions ahead of domestic inflation data.The figures are likely to be closely scrutinised ahead of the release of the Bank of England's November Inflation Report tomorrow along with the monthly unemployment figures.The consumer price index (CPI) is expected to have risen at an annual rate of 2.5% in October, down from 2.7% the month before and representing a six-month low."This would move us closer towards a 'safe' inflation environment where interest rates are unlikely to be raised as a result of high inflation," said Market Analyst Craig Erlam from Alpari. "Thus should we see the CPI figure come in at or below 2.5% it would likely be viewed as positive for a continuation of loose monetary policies going forward," he said. Markets give mixed response to earningsBuilding materials giant CRH gained after reporting a 2% increase in like-for-like sales in the third quarter, a strong turnaround after a 6% decline in the first half owing to difficult weather conditions. The company also hiked its target for cost savings this year after an acceleration in its ongoing spend reduction programme in Europe.Vodafone was subdued early on after the 4.9% fall in second-quarter organic revenues was slightly worse than analysts had forecast. Chief Executive Vittorio Colao admitted trading conditions in Europe remained "very tough".Land Securities edged higher after the property firm posting improved revenue profit and net asset value during the first half and saying it is confident of delivering future progress.Life insurance investment vehicle Resolution erased early losses to trade higher after a mixed third quarter, as significant growth in UK new business in the was outweighed by a more subdued performance overseas.Babcock, the engineering support services company, fell after a broadly in-line first-half report in which it lifted its dividend by 10% following a 32% jump in pre-tax profits.Meanwhile, GlaxoSmithKline fell after its heart disease drug, darapladib, missed a key milestone in its development. FTSE 100 - RisersCRH (CRH) 1,616.00p +3.66%British Sky Broadcasting Group (BSY) 844.00p +1.81%Sainsbury (J) (SBRY) 397.80p +0.96%Rexam (REX) 531.50p +0.66%Antofagasta (ANTO) 823.50p +0.61%ITV (ITV) 188.50p +0.59%Kingfisher (KGF) 388.30p +0.57%Standard Life (SL.) 346.70p +0.55%International Consolidated Airlines Group SA (CDI) (IAG) 384.80p +0.52%Aggreko (AGK) 1,580.00p +0.51%FTSE 100 - FallersFresnillo (FRES) 928.50p -2.52%Anglo American (AAL) 1,447.00p -1.83%Standard Chartered (STAN) 1,484.00p -1.62%Royal Bank of Scotland Group (RBS) 334.60p -1.53%GlaxoSmithKline (GSK) 1,628.50p -1.33%Tullow Oil (TLW) 903.50p -1.31%BG Group (BG.) 1,267.50p -1.13%Coca-Cola HBC AG (CDI) (CCH) 1,747.00p -1.13%Aberdeen Asset Management (ADN) 431.80p -1.10%Mondi (MNDI) 1,039.00p -0.95%FTSE 250 - RisersOxford Instruments (OXIG) 1,356.00p +10.51%TalkTalk Telecom Group (TALK) 265.00p +6.04%Premier Farnell (PFL) 237.80p +4.53%Bank of Georgia Holdings (BGEO) 2,089.00p +3.06%Renishaw (RSW) 1,736.00p +2.18%BTG (BTG) 432.40p +1.91%Dialight (DIA) 913.50p +1.84%Catlin Group Ltd. (CGL) 530.50p +1.24%PZ Cussons (PZC) 378.20p +1.07%Kenmare Resources (KMR) 21.33p +1.04%FTSE 250 - FallersMenzies(John) (MNZS) 772.50p -5.74%Balfour Beatty (BBY) 270.70p -4.51%Hunting (HTG) 829.00p -3.83%Polymetal International (POLY) 549.00p -3.26%Xaar (XAR) 903.50p -2.32%Evraz (EVR) 121.60p -2.17%Synthomer (SYNT) 229.00p -1.89%Rank Group (RNK) 146.50p -1.88%IP Group (IPO) 152.60p -1.86%Daejan Holdings (DJAN) 4,035.00p -1.82%BC
More News
Today 14:01

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.

Read more
Today 11:58

LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence

(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.

Read more
Today 09:08

TOP NEWS: GSK vows to appeal adverse Delaware court ruling on Zantac

(Alliance News) - GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning the heartburn drug, Zantac.

Read more
Today 08:37

LONDON MARKET OPEN: Stocks up amid slew of manufacturing PMIs

(Alliance News) - Stock prices in London opened higher on Monday, ahead of local purchasing managers index data, and comparative prints from several other major global economies.

Read more
Today 08:00

LONDON BRIEFING: FTSE 100 seen up; GSK defends ranitidine cancer claim

(Alliance News) - Stocks in London are set to open higher on Monday, ahead of a data-heavy week, kicked off by a slew of manufacturing purchasing managers' index readings.

Read more
Today 07:30

GSK to appeal Delaware ruling on jury trials in Zantac cancer cases

(Sharecast News) - GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.

Read more
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
27 May 2024 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.